financetom
Business
financetom
/
Business
/
Telephone and Data Systems Swings to Q1 Profit, Operating Revenue Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telephone and Data Systems Swings to Q1 Profit, Operating Revenue Falls
May 3, 2024 6:41 AM

09:26 AM EDT, 05/03/2024 (MT Newswires) -- Telephone and Data Systems ( TDS/PV ) reported Q1 earnings Friday of $0.10 per diluted share, swinging from a loss of $0.08 a year earlier.

Two analysts polled by Capital IQ expected a loss of $0.12.

Operating revenue for the quarter ended March 31 was $1.26 billion, down from $1.30 billion a year earlier.

Two analysts surveyed by Capital IQ expected $1.26 billion.

For 2024, the company continues to expect service revenue of $2.95 billion to $3.05 billion from its United States Cellular (USM) unit and operating revenue of $1.07 billion to $1.10 billion from its TDS Telecom unit.

Shares of the company were up 1.5% in recent Friday premarket activity.

Price: 16.45, Change: +0.24, Percent Change: +1.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Chevron Q2 Production Headwinds to Impact Earnings
Market Chatter: Chevron Q2 Production Headwinds to Impact Earnings
Jun 24, 2024
02:42 PM EDT, 06/24/2024 (MT Newswires) -- Chevron ( CVX ) expects to see a $300 million to $400 million hit on its earnings due to an impact on its Q2 production, Reuters reported Monday. The oil major expects to impact 65,000 barrels of oil equivalent per day in Q2 due to upstream turnarounds and downtime at Tengizchevroil in Kazakhstan...
Why ResMed Shares Are Trading Lower Monday
Why ResMed Shares Are Trading Lower Monday
Jun 24, 2024
ResMed, Inc. ( RMD ) stock is trading lower Monday after Eli Lilly and Company ( LLY ) released data from a clinical trial in regards to the treatment of sleep apnea. The Details: Lilly released data on Friday from its SURMOUNT-OSA phase 3 clinical trial which tested tirzepatide as a treatment for obstructive sleep apnea. This could present a...
Market Chatter: Amazon Working on AI Assistant to Compete With ChatGPT
Market Chatter: Amazon Working on AI Assistant to Compete With ChatGPT
Jun 24, 2024
02:44 PM EDT, 06/24/2024 (MT Newswires) -- Amazon.com ( AMZN ) is working on an AI chatbot codenamed Metis to compete with ChatGPT, Business Insider reported Monday, citing people familiar with the matter and an internal document it obtained. Metis uses retrieval-augmented generation to automate tasks and provide up-to-date information, the report said. (Market Chatter news is derived from conversations...
Market Chatter: Microsoft-G42 Deal 'Positive' After AI Firm Cut Ties With Huawei, White House Official Says
Market Chatter: Microsoft-G42 Deal 'Positive' After AI Firm Cut Ties With Huawei, White House Official Says
Jun 24, 2024
02:45 PM EDT, 06/24/2024 (MT Newswires) -- Microsoft's ( MSFT ) $1.5 billion investment in artificial intelligence firm G42 is a positive development after the United Arab Emirates-based firm cut ties with China's Huawei, a White House official said, Reuters reported Monday. The effort to work with Microsoft ( MSFT ) as an alternative to Huawei is generally a positive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved